An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy

Journal: Nano Letters

Published: 2020-06-11

DOI: 10.1021/acs.nanolett.0c00953

Affiliations: 5

Authors: 10

Go to article
Institutions Share
University of Wisconsin-Madison (UW-Madison), United States of America (USA) 0.95
Yonsei University, South Korea 0.05

Return